Test environment running 7.6.6

Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Interferon alfa-2b for chronic active hepatitis C

Loading...
Thumbnail Image

Date

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

• ■ Interferon produced a complete response in about 70% and a partial response (≥25% reduction ALT) in the remainder of patients treated with Interferon alfa-2b. • ■ Spontaneous, complete or partial resolution of ALT abnormality did not occur in untreated patients. • ■ The fall in serum ALT reflects reduced necroinflammation in liver biopsy. • ■ Six months after interferon, complete remission was sustained for 2 months or more in 40% of patients. • ■ The onset of relapse was often associated with acute hepatitis of greater severity than pretreatment illness.

Description

Keywords

Citation

Source

Journal of Hepatology

Book Title

Entity type

Access Statement

License Rights

Restricted until